1. Home
  2. CI vs BSX Comparison

CI vs BSX Comparison

Compare CI & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Cigna Group

CI

The Cigna Group

HOLD

Current Price

$273.16

Market Cap

71.9B

Sector

Health Care

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$43.42

Market Cap

68.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CI
BSX
Founded
1792
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.9B
68.0B
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
CI
BSX
Price
$273.16
$43.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
22
Target Price
★ $349.00
$93.18
AVG Volume (30 Days)
1.3M
★ 18.2M
Earning Date
04-30-2026
04-22-2026
Dividend Yield
★ 2.13%
N/A
EPS Growth
★ 83.00
55.20
EPS
★ 12.55
1.51
Revenue
★ $274,900,000,000.00
$9,076,000,000.00
Revenue This Year
$5.91
$11.85
Revenue Next Year
$5.92
$10.16
P/E Ratio
★ $21.66
$29.21
Revenue Growth
11.24
★ 12.49
52 Week Low
$239.51
$42.20
52 Week High
$315.47
$105.65

Technical Indicators

Market Signals
Indicator
CI
BSX
Relative Strength Index (RSI) 45.87 39.87
Support Level $271.75 $42.49
Resistance Level $286.84 $46.37
Average True Range (ATR) 5.91 1.12
MACD -0.78 0.03
Stochastic Oscillator 35.68 22.02

Price Performance

Historical Comparison
CI
BSX

About CI The Cigna Group

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.

About BSX Boston Scientific Corporation

Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: